P180 Immune-Oncology (IO) – Tyrosine Kinase Inhibitor (TKI) or IO-IO as first-line treatment in metastatic renal cell carcinoma: What is better in real-world practice?O. Stativko, В. Н. Галкин, В. А. Черняев et al.|European Urology Open Science|2024Cited by 0
Laparoscopic ALPPS procedure: a series of casesVladimir Lyadov, В. Н. Галкин, М. А. Магомедов et al.|Pirogov Russian Journal of Surgery|2025Cited by 0
Experience of 100 laparoscopic liver resections in an oncology hospitalVladimir Lyadov, В. Н. Галкин, А. Н. Москаленко et al.|P A Herzen Journal of Oncology|2025Cited by 0